Skip to search formSkip to main contentSkip to account menu

alosetron 0.5 MG Oral Tablet [Lotronex]

Known as: ALOSETRON HYDROCHLORIDE 0.5 mg ORAL TABLET [LOTRONEX], Lotronex 0.5 MG (alosetron hydrochloride 0.562 MG) Oral Tablet, Lotronex 0.5 MG Oral Tablet 
National Institutes of Health

Related topics

Related topics

11 relations
LactoseLotronexMagnesium stearateOral Tablet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Review: Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome
Irritable bowel syndrome (IBS) is a highly prevalent functional gastrointestinal disorder that causes a range of symptoms… 
2005
2005
Cilansetron: a novel, high-affinity 5-HT3 receptor antagonist for irritable bowel syndrome with diarrhea predominance
Irritable bowel syndrome (IBS) is associated with significant morbidity, impaired quality of life, work absenteeism and high… 
2000
2000
Prucalopride (PRU) is safe and generally well tolerated in elderly patients with chronic constipation (CC)
Purpose: Constipation is a common disorder in the elderly and there is a need for more effective and better-tolerated drugs that… 
2000
2000
Transcutaneous recording of colonic myoelectrical activity: preliminary results
Purpose: Previous studies have recorded myoelectrical activity (ME) from the lumen of the colon primarily in the 6 cpm range. We… 
2000
2000
Alosetron improves bowel function in dumping syndrome patients
Purpose: Dumping syndrome is one of the most common causes of morbidity after gastric surgery. An estimated 25–50% of operated… 
2000
2000
Laxative use in the management of constipation in Lotronex® (Alosetron HCl) treated females with non-constipated irritable bowel syndrome (IBS)
Laxative use in the management of constipation in Lotronex® (Alosetron HCl) treated females with non-constipated irritable bowel… 
2000
2000
Patient satisfaction in Lotronex® (Aloseton HCl) treated nonconstipated irritable bowel syndrome (IBS) females
Patient satisfaction in Lotronex® (Aloseton HCl) treated nonconstipated irritable bowel syndrome (IBS) females 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)